SMAD3 and cancer: Notably, while the suppressive effect of Smad3 signaling on NK cell antitumor activity can only be demonstrated in models with depletion of background immunity9, here we show that Smad3-KO BMDNs are effective in suppressing cancer progression in the immunocompetent TME.